Peptides vs. Pharma

Patrick's innovative supplement, an aromatase inhibitor, highlights the loopholes in supplement regulation. The discussion reveals how traditional pharmaceuticals often prioritize symptom management over root causes, while peptides and bioregulators have the potential to address underlying health issues effectively. This dynamic raises questions about the future of competition in the supplement industry and the reluctance of pharma to embrace these solutions.